Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial (2022)
- Authors:
- USP affiliated authors: KUPA, LEONARD DE VINCI KANDA - FM ; PEREIRA, ROSA MARIA RODRIGUES - FM ; SILVA, CLOVIS ARTUR ALMEIDA DA - FM ; BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM
- Unidade: FM
- DOI: 10.1136/annrheumdis-2021-221916
- Subjects: METOTREXATO; VACINAS VIRAIS; ARTRITE REUMATOIDE
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Annals of the rheumatic diseases
- ISSN: 0003-4967
- Volume/Número/Paginação/Ano: v. 81, n. 6, p. 889-897, 2022
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
ARAUJO, Carlo Scognamiglio Renner et al. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial. Annals of the rheumatic diseases, v. 81, n. 6, p. 889-897, 2022Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2021-221916. Acesso em: 02 abr. 2026. -
APA
Araujo, C. S. R., Medeiros-Ribeiro, A. C., Saad, C. G. S., Bonfiglioli, K. R., Domiciano, D. S., Shimabuco, A. Y., et al. (2022). Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial. Annals of the rheumatic diseases, 81( 6), 889-897. doi:10.1136/annrheumdis-2021-221916 -
NLM
Araujo CSR, Medeiros-Ribeiro AC, Saad CGS, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Kupa L de VK, Pereira RMR, Silva CAA da, Bonfa ESD de O. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 6): 889-897.[citado 2026 abr. 02 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221916 -
Vancouver
Araujo CSR, Medeiros-Ribeiro AC, Saad CGS, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Kupa L de VK, Pereira RMR, Silva CAA da, Bonfa ESD de O. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 6): 889-897.[citado 2026 abr. 02 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221916 - Thalidomide measurement in plasma and dried plasma spot by SPE combined with UHPLC-MS/MS for therapeutic drug monitoring
- SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy
- Immunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1/2009 vaccine in young autoimmune rheumatic diseases patients
- Symptomatic polyautoimmunity at diagnosis of 1463 childhood-onset lupus: a Brazilian multicenter study
- Subclinical Pulmonary Hypertension in Childhood Systemic Lupus Erythematosus Associated with Minor Disease Manifestations
- Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis
- Panniculitis in childhood-onset systemic lupus erythematosus: a multicentric cohort study
- Distinct clinical correlates of immune thrombocytopenic purpura at diagnosis of childhood-onset and adult SLE
- Diffuse alveolar hemorrhage in childhood-onset systemic lupus erythematosus: a severe disease flare with serious outcome
- Chronic arthritis in systemic lupus erythematosus: distinct features in 336 paediatric and 1830 adult patients
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
